Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges

Breast cancer (BC) is the most common women cancer and cause of cancer death. Despite decades of scientific progress in BC treatments, the clinical benefit of new drugs is modest in several cases. The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerma, Krisida, Piacentini, Federico, Moscetti, Luca, Barbolini, Monica, Canino, Fabio, Tornincasa, Antonio, Caggia, Federica, Cerri, Sara, Molinaro, Alessia, Dominici, Massimo, Omarini, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855880/
https://www.ncbi.nlm.nih.gov/pubmed/36672617
http://dx.doi.org/10.3390/biomedicines11010109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855880/
https://www.ncbi.nlm.nih.gov/pubmed/36672617
http://dx.doi.org/10.3390/biomedicines11010109

Ejemplares similares